Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge J Castillo

Showing results (91-100 of 343) with videos related to

Pageof 35
Sort By:
Leukemia Research|October 1, 2017
Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat diseaseThomas A Guerrero-Garcia, Renzo J Mogollon, Jorge J Castillo
Therapeutic Advances in Hematology|August 6, 2016
Ibrutinib in Waldenström macroglobulinemia: latest evidence and clinical experienceJorge J Castillo, M Lia Palomba, Ranjana Advani, et al.
Leukemia & Lymphoma|February 11, 2021
Clinical application of genomics in Waldenström macroglobulinemiaAndrew R Branagan, Mathew Lei, Steven P Treon, et al.
Leukemia Research|September 11, 2010
Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphomaBrady Beltran, Pilar Quiñones, Domingo Morales, et al.
American Journal of Hematology|January 3, 2014
Primary refractory Hodgkin lymphoma: limited options and poor survival--but not alwaysAruna Gavini, John L Reagan, Eric S Winer, et al.
Expert Review of Hematology|June 16, 2017
Novel approaches to targeting MYD88 in Waldenström macroglobulinemiaJorge J Castillo, Zachary R Hunter, Guang Yang, et al.
Hematology/Oncology Clinics of North America|September 13, 2014
Waldenström macroglobulinemiaSteven P Treon, Zachary R Hunter, Jorge J Castillo, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 18, 2025
SOHO State of the Art Updates and Next Questions | The Optimal Management of Waldenström MacroglobulinemiaAlberto Guijosa, Alicia de Las Heras, Shayna Sarosiek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2023
Does Bortezomib-Dexamethasone-Rituximab-Cyclophosphamide Play a Role in the Treatment of Waldenström's Macroglobulinemia?Shayna Sarosiek, Steven P Treon, Andrew R Branagan, et al.
British Journal of Haematology|February 19, 2014
Viral lymphomagenesis: from pathophysiology to the rationale for novel therapiesJorge J Castillo, John L Reagan, Kenneth D Bishop, et al.
Pageof 35

Showing results (91-100 of 343) with videos related to

Sort By:
Pageof 35
Leukemia Research|October 1, 2017
Bortezomib in plasmablastic lymphoma: A glimpse of hope for a hard-to-treat diseaseThomas A Guerrero-Garcia, Renzo J Mogollon, Jorge J Castillo
Therapeutic Advances in Hematology|August 6, 2016
Ibrutinib in Waldenström macroglobulinemia: latest evidence and clinical experienceJorge J Castillo, M Lia Palomba, Ranjana Advani, et al.
Leukemia & Lymphoma|February 11, 2021
Clinical application of genomics in Waldenström macroglobulinemiaAndrew R Branagan, Mathew Lei, Steven P Treon, et al.
Leukemia Research|September 11, 2010
Different prognostic factors for survival in acute and lymphomatous adult T-cell leukemia/lymphomaBrady Beltran, Pilar Quiñones, Domingo Morales, et al.
American Journal of Hematology|January 3, 2014
Primary refractory Hodgkin lymphoma: limited options and poor survival--but not alwaysAruna Gavini, John L Reagan, Eric S Winer, et al.
Expert Review of Hematology|June 16, 2017
Novel approaches to targeting MYD88 in Waldenström macroglobulinemiaJorge J Castillo, Zachary R Hunter, Guang Yang, et al.
Hematology/Oncology Clinics of North America|September 13, 2014
Waldenström macroglobulinemiaSteven P Treon, Zachary R Hunter, Jorge J Castillo, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 18, 2025
SOHO State of the Art Updates and Next Questions | The Optimal Management of Waldenström MacroglobulinemiaAlberto Guijosa, Alicia de Las Heras, Shayna Sarosiek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2023
Does Bortezomib-Dexamethasone-Rituximab-Cyclophosphamide Play a Role in the Treatment of Waldenström's Macroglobulinemia?Shayna Sarosiek, Steven P Treon, Andrew R Branagan, et al.
British Journal of Haematology|February 19, 2014
Viral lymphomagenesis: from pathophysiology to the rationale for novel therapiesJorge J Castillo, John L Reagan, Kenneth D Bishop, et al.
Pageof 35